4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-032740
Chief Executive Officer sold 2,924 shares at $60.91 ($178,098)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BELANOFF JOSEPH K Chief Executive Officer | 2025-03-03 | Sale 10b5-1 | −2,924 | $60.91 | $178,098 | 3,019,411 | I: show line 1 in the form |
| Open-market sales · 2,924 sh · avg $60.91 · $178,098 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BELANOFF JOSEPH K Chief Executive Officer | 2025-02-28 | Grant or award · Stock option (right to buy) 10b5-1 | +350,000 | 350,000 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…